Skip to content
M

Muhammad Sadik Memon

Publications (2)

Association of Non-alcoholic Fatty Liver Disease with Symptomatic and Asymptomatic Cholelithiasis: Cohort from Southeast Asian Patients

Abdul Hafeez Soomro, Jawaid Iqbal, Rehmatullah Bhatti, Falak Naz, Muhammad Arsalan & Muhammad Sadik Memon · Journal of Pharmaceutical Research International · 2022

Introduction: With increasing prevalence of metabolic syndrome, sedentary lifestyle, and diabetes mellitus the burden of non-alcoholic fatty liver disease (NAFLD) is also increasing along with its complications including gallstone disease. That is why, this study aims to determin...

Open access Research Article 10.9734/jpri/2022/v34i14A35647

Safety of Sofosbuvir/Daclatasvir and Sofosbuvir/ Ribavirin in Children and Adolescents with Chronic Hepatitis C

Adil Hassan Chang, Ubedullah Bughio, Rehmatullah Bhatti, Laraib Jamali, Bushra Kadir & Muhammad Sadik Memon · Journal of Pharmaceutical Research International · 2022

Introduction: Sofosbuvir/ribavirin and sofosbuvir/ledipasvir regimes are approved by European Association for Study of Liver (EASL) for Chronic Hepatitis C (CHC) infection in adolescents although none of the combinations is approved for age below twelve years. Objective: The aim...

Open access Research Article 10.9734/jpri/2022/v34i12B35557